New patent expiration for Cubist Pharms drug ENTEREG
Annual Drug Patent Expirations for ENTEREG Entereg is a drug marketed by Cubist Pharms and is included in one NDA. […]
New patent expiration for Cubist Pharms drug ENTEREG Read Post »
Patent Expiration
New patent expiration for Medtech Products drug MONISTAT 1 COMBINATION PACK
Annual Drug Patent Expirations for MONISTAT+1+COMBINATION+PACK Monistat 1 Combination Pack is a drug marketed by Medtech Products and is included
New patent expiration for Medtech Products drug MONISTAT 1 COMBINATION PACK Read Post »
New patent expiration for Novartis drug FORADIL
Annual Drug Patent Expirations for FORADIL Foradil is a drug marketed by Novartis and is included in two NDAs. There
New patent expiration for Ucb Inc drug NEUPRO
Annual Drug Patent Expirations for NEUPRO Neupro is a drug marketed by Ucb Inc and is included in one NDA.
Drug Patent Expirations for the Week of November 22, 2020
RISPERDAL CONSTA (risperidone) Janssen pharms Patent: 6,667,061 Expiration: Nov 25, 2020 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of November 22, 2020 Read Post »
New patent expiration for Janssen Pharms drug RISPERDAL CONSTA
Annual Drug Patent Expirations for RISPERDAL+CONSTA Risperdal Consta is a drug marketed by Janssen Pharms and is included in one
New patent expiration for Janssen Pharms drug RISPERDAL CONSTA Read Post »
New patent expiration for Melinta Therap drug ORBACTIV
Annual Drug Patent Expirations for ORBACTIV Orbactiv is a drug marketed by Melinta Therap and is included in one NDA.
New patent expiration for Melinta Therap drug ORBACTIV Read Post »
New patent expiration for AGILE drug TWIRLA
Annual Drug Patent Expirations for TWIRLA Twirla is a drug marketed by Agile and is included in one NDA. There
New patent expiration for Merck Sharp drug DULERA
Annual Drug Patent Expirations for DULERA Dulera is a drug marketed by Merck Sharp Dohme and is included in one
New patent expiration for Merck Sharp drug DULERA Read Post »
